Idursulfase (Elaprase)

Enzyme replacement therapy (recombinant iduronate-2-sulfatase)

Idursulfase (Elaprase)

Forms and strengths
Form: TabletStrength: 2 mg/mL (6 mg/3 mL vial)
Print

Indication

  • Idursulfase is used for long-term enzyme replacement therapy in patients with Hunter syndrome (mucopolysaccharidosis II, MPS II).

Rejoining the server...

Rejoin failed... trying again in seconds.

Failed to rejoin.
Please retry or reload the page.

The session has been paused by the server.

Failed to resume the session.
Please retry or reload the page.